Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLVI.i

Acute pulmonary hypertension

Can cause catastrophic hemodynamic instability. Occurs electively in the intra/perioperative period, during heparin reversal

Publications

Jerath A, Srinivas C, Vegas A, Brister S

The successful management of severe protamine-induced pulmonary hypertension using inhaled prostacyclin.

Anesthesia and analgesia 2010 Feb 01;110;365-9 — 2010 Feb 01 — 365-9

Hiong YT, Tang YK, Chui WH, Das SR

A case of catastrophic pulmonary vasoconstriction after protamine administration in cardiac surgery: role of intraoperative transesophageal echocardiography.

Journal of cardiothoracic and vascular anesthesia 2008 Oct;22;727-31 — 2008 Oct — 727-31

Ralley FE

The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration.

Anesthesia and analgesia 1999 Mar;88;505-7 — 1999 Mar — 505-7

Lowenstein E, Zapol WM

Protamine reactions, explosive mediator release, and pulmonary vasoconstriction.

Anesthesiology 1990 Sep;73;373-5 — 1990 Sep — 373-5